Comparison of the therapeutic effects of levetiracetam and sodium valproate on the containment of migraine headaches
Phase 4
- Conditions
- 52 patients suffering from migraine were evenly assigned to two groups of A (receivers of sodium valproate) and B (receivers of levetiracetam). Patients of both groups visited the hospital in three moLevetiracetamsodium valproatemigraine headaches
- Registration Number
- TCTR20161213001
- Lead Sponsor
- Azad Islamic University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Inclusion criteria included: diagnosis of migraine based on the criteria of International Headache Society, 6 months of migraine attacks with auras, and no history of diseases that are compounded with headaches, consumption of prophylaxis for migraine in last 6 months.
Exclusion Criteria
drugs leading to headaches including Nitrogen compounds, oral contraceptive pills and alcohol. Patients who were not interested in the study, or the prescribed medicine was not effective in them, were discarded from the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method migraine 3 months after the end of intervention visual Analog Scale
- Secondary Outcome Measures
Name Time Method headache reduction 3 months after the end of intervention visual Analog Scale